- Home
- Publications
- Publication Search
- Publication Details
Title
Activity of T-DM1 in Her2-positive breast cancer brain metastases
Authors
Keywords
Breast cancer, Brain metastases, Her2 positive, T-DM1, Systemic therapy
Journal
CLINICAL & EXPERIMENTAL METASTASIS
Volume 32, Issue 7, Pages 729-737
Publisher
Springer Nature
Online
2015-08-25
DOI
10.1007/s10585-015-9740-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Response assessment criteria for brain metastases: proposal from the RANO group
- (2015) Nancy U Lin et al. LANCET ONCOLOGY
- Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA
- (2014) I. E. Krop et al. ANNALS OF ONCOLOGY
- Capecitabine and lapatinib uptake in surgically resected brain metastases from metastatic breast cancer patients: a prospective study
- (2014) Aki Morikawa et al. NEURO-ONCOLOGY
- Challenges relating to solid tumour brain metastases in clinical trials, part 1: patient population, response, and progression. A report from the RANO group
- (2013) Nancy U Lin et al. LANCET ONCOLOGY
- Brain metastases free survival differs between breast cancer subtypes
- (2012) A Berghoff et al. BRITISH JOURNAL OF CANCER
- Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
- (2012) Thomas Bachelot et al. LANCET ONCOLOGY
- Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
- (2012) Sunil Verma et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases
- (2011) R Bartsch et al. BRITISH JOURNAL OF CANCER
- Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabine
- (2010) G. Metro et al. ANNALS OF ONCOLOGY
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- DEGRO Practical Guidelines for Palliative Radiotherapy of Breast Cancer Patients: Brain Metastases and Leptomeningeal Carcinomatosis
- (2010) Petra Feyer et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer
- (2009) Rupert Bartsch et al. BMC CANCER
- Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer
- (2009) N. U. Lin et al. CLINICAL CANCER RESEARCH
- Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
- (2009) Eric L Chang et al. LANCET ONCOLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2008) Nancy U. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started